Royalty Pharma
RPRX
RPRX
134 hedge funds and large institutions have $6.52B invested in Royalty Pharma in 2020 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $7.04B → $6.52B (-$514M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less call options, than puts
Call options by funds: $5.21M | Put options by funds: $6.43M
Holders
134
Holding in Top 10
6
Calls
$5.21M
Puts
$6.43M
Top Buyers
| 1 | +$133M | |
| 2 | +$94.1M | |
| 3 | +$75.9M | |
| 4 |
BlackRock
New York
|
+$70.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$41.1M |
Top Sellers
| 1 | -$66.5M | |
| 2 | -$36M | |
| 3 | -$33.9M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$23.9M |
| 5 |
AG
Artal Group
Luxembourg
|
-$21M |